Cargando…
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
Sarcoma botryoides of the cervix is an extremely rare tumour and seems to be associated with a better prognosis than its vaginal counterpart. Recent studies have suggested that it is possible to limit surgery to local excision in stage I cases. We report three cases of young subjects treated success...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362332/ https://www.ncbi.nlm.nih.gov/pubmed/10408845 http://dx.doi.org/10.1038/sj.bjc.6690370 |
_version_ | 1782153431617634304 |
---|---|
author | Zanetta, G Rota, S M Lissoni, A Chiari, S Bratina, G Mangioni, C |
author_facet | Zanetta, G Rota, S M Lissoni, A Chiari, S Bratina, G Mangioni, C |
author_sort | Zanetta, G |
collection | PubMed |
description | Sarcoma botryoides of the cervix is an extremely rare tumour and seems to be associated with a better prognosis than its vaginal counterpart. Recent studies have suggested that it is possible to limit surgery to local excision in stage I cases. We report three cases of young subjects treated successfully with polypectomy or diathermy loop excision followed by adjuvant chemotherapy. One patient had a local recurrence which was treated with further local excision. All subjects remain alive without evidence of recurrence and with normal menstrual function 36, 38 and 38 months following initial diagnosis. A conservative surgical approach to early cervical sarcoma botryoides is possible. The efficacy of adjuvant chemotherapy and the regimen of choice still need to be investigated. © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2362332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23623322009-09-10 Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females Zanetta, G Rota, S M Lissoni, A Chiari, S Bratina, G Mangioni, C Br J Cancer Regular Article Sarcoma botryoides of the cervix is an extremely rare tumour and seems to be associated with a better prognosis than its vaginal counterpart. Recent studies have suggested that it is possible to limit surgery to local excision in stage I cases. We report three cases of young subjects treated successfully with polypectomy or diathermy loop excision followed by adjuvant chemotherapy. One patient had a local recurrence which was treated with further local excision. All subjects remain alive without evidence of recurrence and with normal menstrual function 36, 38 and 38 months following initial diagnosis. A conservative surgical approach to early cervical sarcoma botryoides is possible. The efficacy of adjuvant chemotherapy and the regimen of choice still need to be investigated. © 1999 Cancer Research Campaign Nature Publishing Group 1999-05 1999-05-01 /pmc/articles/PMC2362332/ /pubmed/10408845 http://dx.doi.org/10.1038/sj.bjc.6690370 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Zanetta, G Rota, S M Lissoni, A Chiari, S Bratina, G Mangioni, C Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
title | Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
title_full | Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
title_fullStr | Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
title_full_unstemmed | Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
title_short | Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
title_sort | conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362332/ https://www.ncbi.nlm.nih.gov/pubmed/10408845 http://dx.doi.org/10.1038/sj.bjc.6690370 |
work_keys_str_mv | AT zanettag conservativetreatmentfollowedbychemotherapywithdoxorubicinandifosfamideforcervicalsarcomabotryoidesinyoungfemales AT rotasm conservativetreatmentfollowedbychemotherapywithdoxorubicinandifosfamideforcervicalsarcomabotryoidesinyoungfemales AT lissonia conservativetreatmentfollowedbychemotherapywithdoxorubicinandifosfamideforcervicalsarcomabotryoidesinyoungfemales AT chiaris conservativetreatmentfollowedbychemotherapywithdoxorubicinandifosfamideforcervicalsarcomabotryoidesinyoungfemales AT bratinag conservativetreatmentfollowedbychemotherapywithdoxorubicinandifosfamideforcervicalsarcomabotryoidesinyoungfemales AT mangionic conservativetreatmentfollowedbychemotherapywithdoxorubicinandifosfamideforcervicalsarcomabotryoidesinyoungfemales |